|drug2734||Questionnaire by phone call Wiki||1.00|
|drug491||Blood sampling Wiki||0.35|
|D012859||Sjogren's Syndrome NIH||0.58|
|D015535||Arthritis, Psoriatic NIH||0.50|
|D008180||Lupus Erythematosus, Systemic NIH||0.41|
There is one clinical trial.
The recent and unexpected occurrence of patients with the development of skin lesions on the hands and/ or feet has been described recently. As these cases occurred contemporaneously with the Coronavirus Disease 2019 (COVID-19) and as it was the most often occurrence of de novo frostbites, the question raised of whether there is a direct link between the occurrence of these lesions and infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) the responsible for CoVID-19. Indeed, mechanisms of these lesions and the precise correlation with Sars-CoV-2 remains poorly understood. Therefore, this study aim to: 1. Determine the possible link with this virus, 2. Understand the mechanisms involved in the pathogenesis of these lesions.
Description: SARS-CoV-2 will be tested by Polymorphism Chain Reaction (PCR) (on the first day of consultation) and serological analysis ( at day 0 and day 15 after the first consultation)Measure: Detection of SARS-CoV-2 by real-time PCR and serological test Time: assessing change between day 0 and day 15
Description: Metagenomics analysis will be performed on nasopharyngeal, tonsil and perianal samplesMeasure: Detection of SARS-CoV-2 by metagenomics analysis Time: Up to 2.5 months after inclusion
Description: Transcriptomic analysis will be conducted with RNA extracted from frozen skin samplesMeasure: Detection of acrosyndrome by transcriptomic analysis of skin samples Time: Up to 2.5 months after inclusion
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports